MedPath
HSA Product

PROCTOSEDYL SUPPOSITORY

Product approved by Health Sciences Authority (SG)

Basic Information

PROCTOSEDYL SUPPOSITORY

SUPPOSITORY

Regulatory Information

SIN01717P

June 8, 1988

Prescription Only

Therapeutic

RECTAL

August 10, 2023

June 3, 2025

XC05AA01

Company Information

OPELLA HEALTHCARE SINGAPORE PTE. LTD.

OPELLA HEALTHCARE SINGAPORE PTE. LTD.

Active Ingredients

NEOMYCIN B SULPHATE

Strength: 10 mg

ESCULOSIDE

Strength: 10 mg

DIBUCAINE HCl

Strength: 5 mg

HYDROCORTISONE

Strength: 5 mg

Detailed Information

Contraindications

**Contra-indications:** Known hyper-sensitivity to any of the ingredients. In pregnant animals administration of corticosteroid can cause abnormalities of foetal development. The relevance of this finding to human beings has not been established. However, topical steroids should not be used extensively in pregnancy, ie in large amounts of for long periods. Hydrocortisone may pass into human breast milk. This product should not be used in pregnancy or lactation unless considered essential by the physician. Topical corticosteroid preparations are contra-indicated in the presence of untreated infections of viral, bacterial, tuberculous, parasitic or fungal origin.

Indication Information

**Indications:** 1. For the treatment of internal and external haemorrhoids 2. Haemorrhoids in pregnancy and post-partum 3. Anal pruritus, peri-anal eczema, anal fissures and proctitis 4. Post-haemorrhoidectomy application to relieve pain and discomfort

© Copyright 2025. All Rights Reserved by MedPath